MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 1

Completed

Conditions: Lymphocytic Leukemia

Interventions: Drug: alemtuzumab
Drug: everolimus

First Posted Date: 2009-07-09

Last Posted Date: 2017-09-26

Lead Sponsor: Mayo Clinic

Target Recruit Count: 28

Registration Number: NCT00935792

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Varenicline and Bupropion for Smoking Cessation

Phase 2

Completed

Conditions: Smoking

Interventions: Drug: Varenicline
Drug: placebo
Drug: bupropion SR

First Posted Date: 2009-07-09

Last Posted Date: 2014-05-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 506

Registration Number: NCT00935818

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
University Of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Franciscan Skemp Hospital, LaCrosse, Wisconsin, United States

Intestinal Microecology in Chronic Constipation

Phase 1

Completed

Conditions: Other Constipation
Irritable Bowel Syndrome

Interventions: Drug: Lubiprostone

First Posted Date: 2009-07-08

Last Posted Date: 2013-07-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 21

Registration Number: NCT00934479

Locations: 🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States

Polycystic Liver Disease in Kidney Transplant

Not Applicable

Terminated

Conditions: Polycystic Liver Disease

Interventions: Drug: Sirolimus
Drug: Tacrolimus
Drug: Mycophenolate Mofetil
Drug: Prednisone

First Posted Date: 2009-07-08

Last Posted Date: 2013-03-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 2

Registration Number: NCT00934791

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy

Phase 4

Completed

Conditions: Urinary Incontinence

Interventions: Procedure: Burch urethropexy
Procedure: Synthetic mid-urethral sling (TVT)

First Posted Date: 2009-07-08

Last Posted Date: 2023-08-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 113

Registration Number: NCT00934999

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

Phase 1

Completed

Conditions: Recurrent Adult Hodgkin Lymphoma
Recurrent Grade 1 Follicular Lymphoma
Recurrent Marginal Zone Lymphoma
T-cell Adult Acute Lymphoblastic Leukemia
Adult Nasal Type Extranodal NK/T-cell Lymphoma
Anaplastic Large Cell Lymphoma
Nodal Marginal Zone B-cell Lymphoma
Post-transplant Lymphoproliferative Disorder
Recurrent Adult Acute Lymphoblastic Leukemia
Recurrent Grade 3 Follicular Lymphoma

Interventions: Drug: panobinostat
Drug: everolimus
Other: laboratory biomarker analysis
Other: pharmacological study

First Posted Date: 2009-06-11

Last Posted Date: 2020-03-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 124

Registration Number: NCT00918333

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mark O Hatfield-Warren Grant Magnuson Clinical Center, Bethesda, Maryland, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Greater Occipital Nerve Block for Migraine Prophylaxis

Phase 4

Completed

Conditions: Migraine Headache

Interventions: Drug: bupivicaine
Drug: normal saline
Drug: methylprednisolone
Drug: lidocaine

First Posted Date: 2009-06-08

Last Posted Date: 2014-03-20

Lead Sponsor: Mayo Clinic

Target Recruit Count: 70

Registration Number: NCT00915473

Locations: 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States

Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid

Completed

Conditions: Bronchoscopy

First Posted Date: 2009-06-08

Last Posted Date: 2011-11-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 300

Registration Number: NCT00915941

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States

Cheno Effect on Transit in Health and IBS-C

Phase 2

Completed

Conditions: Constipation-predominant Irritable Bowel Syndrome

Interventions: Drug: Sodium chenodeoxycholate (NaCDC)
Other: Placebo

First Posted Date: 2009-06-03

Last Posted Date: 2012-07-02

Lead Sponsor: Mayo Clinic

Target Recruit Count: 36

Registration Number: NCT00912301

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial

Not Applicable

Completed

Conditions: Atrial Fibrillation
Arrhythmia

Interventions: Device: Left atrial ablation
Drug: Rate or Rhythm Control Therapy

First Posted Date: 2009-06-02

Last Posted Date: 2021-04-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 2204

Registration Number: NCT00911508

Locations: 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸
Drexel University College of Medicine, Philadelphia, Pennsylvania, United States
🇺🇸
Good Samaritan Hospital, Los Angeles, California, United States

and more 115 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy